Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.
Abstract
Mitochondria play a central role in a plethora of processes related to the maintenance of cellular homeostasis and genomic integrity. They contribute to preserving the optimal functioning of cells and protecting them from potential DNA damage which could result in mutations and disease. However, perturbations of the system due to senescence or environmental factors induce alterations of the physiological balance and lead to the impairment of mitochondrial functions. After the description of the crucial roles of mitochondria for cell survival and activity, the core of this review focuses on the “mitochondrial switch” which occurs at the onset of neuronal degeneration. We dissect the pathways related to mitochondrial dysfunctions which are shared among the most frequent or disabling neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, Amyotrophic Lateral Sclerosis, and Spinal Muscular Atrophy. Can mitochondrial dysfunctions (affecting their morphology and activities) represent the early event eliciting the shift towards pathological neurobiological processes? Can mitochondria represent a common target against neurodegeneration? We also review here the drugs that target mitochondria in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial dysfunction has been reported in a number of neurodegenerative diseases [3–6] and correlates with dendritic pathology and synapse disassembly [7–10].”
From AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kandimalla, R., Manczak, M., Yin, X., Wang, R., & Reddy, P. H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx381 · Cited by 260 · cited 1×
“Neurodegenerative diseases consist of a group of heterogeneous disorders, but, nevertheless, they are all characterized by the progressive loss of specific neuronal populations and circuits in the central nervous system (CNS) triggered by mitochondria dysfunctions [23,24].”
BackgroundRetractedFree Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Additionally, also in PD, mitochondrial dysfunctions are not limited to CNS, but also involve peripheral tissues as it has been described in skeletal muscles and platelets [62,75].”
BackgroundThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“Interestingly, NLRP3 localizes in the cytosol and once activated it translocates into mitochondria and mitochondria-associated membranes (MAMs) [37].”
BackgroundGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1×
“The first evidence of mitochondrial dysfunction in PD came in 1983, when Langston described chronic parkinsonism effects in young humans after the use of 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is a prodrug to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+); the latter interferes with the activity…”
BackgroundOxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 1×
“Indeed, the processes of fusion and fission are fundamental, respectively, to repair a damaged mitochondrion or to increment their number, as in case of an increased demand of energy or to facilitate their removal when damaged in order to protect cellular integrity [12].”
Background
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
Kaplan, P., Tatarkova, Z., Sivonova, M. K., Racay, P., & Lehotsky, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207698 · Cited by 196
“of the above-mentioned neurodegenerative and cardiovascular diseases [22].”
BackgroundDeregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
Zhang, S., Gai, Z., Gui, T., Chen, J., Chen, Q., & Li, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6139308 · Cited by 156
“PCA is also regarded as the perfect peroxyl radical scavenger in the polar environment of aqueous solutions and a relatively good anti-radical protector in nonpolar environment of lipid solutions [92].”
BackgroundFields, M., Marcuzzi, A., Gonelli, A., Celeghini, C., Maximova, N., & Rimondi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043739 · Cited by 156
“[4] determined that mitochondrial dysfunctions represent a crucial point of convergence in the pathogenesis of such neurodegenerative pathologies.”
Background
Metadata
- Authors
- Stanga, S., Caretto, A., Boido, M., & Vercelli, A.
- Affiliations
- Neuroscience Institute Cavalieri Ottolenghi (IT)
- Corresponding author
- Stanga, Serena
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 21
- Issue
- 10
- Pages
- 3719
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7279270
- OpenAlex
- W3026090014
- Cited by
- 90
- References
- 244
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 23 · 2020: 10
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (“Dipartimenti di Eccellenza 2018–2022” to Department of Neuroscience “Rita Levi Montalcini)
- Fondazione CRT (RF 2017.2052)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial dysfunction, neurodegenerative diseases, neurodegeneration, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, mitochondrial morphology, mitochondrial-targeted drugs, cellular senescence, DNA damage
- MeSH terms
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Antioxidants, Organelle Biogenesis, Humans, Mitochondria, Muscular Atrophy, Spinal, Parkinson Disease, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. https://app.cochat.ai/papers/10.3390/ijms21103719
- The paper
- Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020). Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21103719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.